1. Abbara A, Clarke S, Eng PC, Milburn J, Joshi D, Comninos AN, Ramli R, Mehta A, Jones B, Wernig F, Nair R, Mendoza N, Sam AH, Hatfield E, Meeran K, Dhillo WS, Martin NM (2018) Clinical and biochemical characteristics of patients presenting with pituitary apoplexy. Endocr Connect 7: 1058-1066
2. Albani A, Ferraù F, Angileri FF, Esposito F, Granata F, Ferreri F, Cannavò S (2016) Multidisciplinary management of pituitary apoplexy. Int J Endocrinol 2016: 7951536
3. Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P (2015) Pituitary apoplexy. Endocr Rev 36: 622-645
4. Cardoso ER, Peterson EW (1984) Pituitary apoplexy: a review. Neurosurgery 14: 363–373
5. Deepak D, Daousi C, Javadpour M, MacFarlane IA (2007) Macroprolactinomas and epilepsy. Clin Endocrinol (Oxf) 66: 503-507
6. Elkington SG (1968) Pituitary adenoma: preoperative symptomatology in a series of 260 patients. Br J Ophthalmol 52: 322-328
7. Fan Y, Bao X, Wang R (2018) Conservative treatment cures an elderly pituitary apoplexy patient with oculomotor paralysis and optic nerve compression: a case report and systematic review of the literature. Clin Interv Aging 13: 1981-1985
8. Giammattei L, Mantovani G, Carrabba G, Ferrero S, Di Cristofori A, Verrua E, Guastella C, Pignataro L, Rampini P, Minichiello M, Locatelli M (2016) Pituitary apoplexy: considerations on a single center experience and review of the literature. J Endocrinol Invest 39:739-746
9. Giritharan S, Gnanalingham K, Kearney T (2016) Pituitary apoplexy: bespoke patient management allows good clinical outcome. Clin Endocrinol (Oxf) 85: 415-422
10. Glezer A, Bronstein MD (2015) Pituitary apoplexy: pathophysiology, diagnosis and management. Arch Endocrinol Metab 59: 259-264
11. Grzywotz A, Kleist B, Möller LC, Hans VH, Göricke S, Sure U, Müller O, Kreitschmann-Andermahr I (2017) Pituitary apoplexy: a single center retrospective study from the neurosurgical perspective and review of the literature. Clin Neurol Neurosurg 163: 39-45
12. Hage R, Eshraghi SR, Oyesiku NM, Ioachimescu AG, Newman NJ, Biousse V, Bruce BB (2016) Third, fourth, and sixth cranial nerve palsies in pituitary apoplexy. World Neurosurg 94: 447-452
13. Kerr JM, Wierman ME (2011) Pituitary apoplexy. BMJ 342: d1270
14. Kleinschmidt-Demasters BK, Lillehei KO (1998) Pathological correlates of pituitary adenomas presenting with apoplexy. Hum Pathol 29: 1255-1265
15. Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33: 610-618
16. Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. New England J Med 342: 314-319
17. Niwa J, Tanabe S, Hashi K (1996) Seizures as a late complication of bromocriptine therapy in patients with prolactin-producing macroadenomas: correlation between lateral extension of the adenoma and seizure onset. No Shinkei Geka 24: 913-919
18. Pyrgelis ES, Mavridis I, Meliou M (2018) Presenting symptoms of pituitary apoplexy. J Neurol Surg A Cent Eur Neurosurg 79: 52-59
19. Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, Markey A, Plant G, Powell M, Sinha S, Wass J (2011) UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf) 74: 9-20
20. Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA (1999) Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol 51: 181-188
21. Ricciuti R, Nocchi N, Arnaldi G, Polonara G, Luzi M (2018) Pituitary adenoma apoplexy: review of personal series. Asian J Neurosurg 13: 560-564
22. Schindler K, Christ ER, Mindermann T, Wieser HG (2006) Transient MR changes and symptomatic epilepsy following gamma knife treatment of a residual GH-secreting pituitary adenoma in the cavernous sinus. Acta Neurochir (Wien) 148: 903-908
23. Tomson T, Beghi E, Sundqvist A, Johannessen SI (2004) Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention. Epilepsy Res 60: 1-16
24. Tu M, Lu Q, Zhu P, Zheng W (2016) Surgical versus non-surgical treatment for pituitary apoplexy: a systematic review and meta-analysis. J Neurol Sci 370: 258-262
25. Turgut M, Ozsunar Y, Başak S, Güney E, Kir E, Meteoğlu I (2010) Pituitary apoplexy: an overview of 186 cases published during the last century. Acta Neurochir (Wien) 152: 749-761
26. Vicente A, Lecumberri B, Gálvez MÁ; Grupo de Trabajo de Neuroendocrinología (2013) Clinical practice guideline for the diagnosis and treatment of pituitary apoplexy. Endocrinol Nutr 60:582.e1-582.e12
27. Wildemberg LE, Glezer A, Bronstein MD, Gadelha MR (2018) Apoplexy in nonfunctioning pituitary adenomas. Pituitary 21: 138-144
28. Yoshino A, Katayama Y, Watanabe T, Ogino A, Ohta T, Komine C, Yokoyama T, Fukushima T, Hirota H (2007) Apoplexy accompanying pituitary adenoma as a complication of preoperative anterior pituitary function test. Acta Neurochir (Wien) 149: 557-565
29. Zhan R, Li X, Li X (2016) Endoscopic endonasal transsphenoidal approach for apoplectic pituitary tumor: surgical outcomes and complications in 45 patients. J Neurol Surg B Skull Base 77: 54-60